We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+8.27%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$21.8B
AUM Growth
+$3.36B
Cap. Flow
+$2.78B
Cap. Flow %
12.74%
Top 10 Hldgs %
12.04%
Holding
3,109
New
1,280
Increased
559
Reduced
519
Closed
699

Sector Composition

Rank Sector Weight
1 Healthcare 20.03%
2 Consumer Discretionary 13.15%
3 Technology 10.68%
4 Financials 9.81%
5 Communication Services 8.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HYG icon
26
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$16.3B
$111M 0.51%
+1,268,903
New +$110M
QQQ icon
27
PUT
Invesco QQQ Trust
QQQ
$455B
$110M 0.51%
345,900
+80,900
+31% +$25.9M
LQD icon
28
CALL
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$34.7B
$108M 0.49%
+830,000
New +$110M
TWST icon
29
Twist Bioscience
TWST
$5.62B
$106M 0.49%
854,512
+326,930
+62% +$49.6M
VIPS icon
30
Vipshop
VIPS
$6.84B
$106M 0.48%
3,540,903
+3,141,629
+787% +$108M
IQ icon
31
iQIYI
IQ
$1.18B
$97.9M 0.45%
+5,891,855
New +$136M
TECH icon
32
Bio-Techne
TECH
$11.2B
$96.8M 0.44%
1,013,416
+1,006,308
+14,157% +$91.8M
ITCI
33
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$96.2M 0.44%
2,834,460
-181,272
-6% -$6.29M
DISCK
34
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
$96.1M 0.44%
2,605,889
+863,078
+50% +$36.6M
T icon
35
AT&T
T
$165B
$91.6M 0.42%
4,008,082
+3,950,908
+6,910% +$87.4M
SKX
36
DELISTED
Skechers
SKX
$90.7M 0.42%
2,175,073
-696,420
-24% -$26.3M
PINS icon
37
Pinterest
PINS
$12.4B
$88.8M 0.41%
1,199,232
+954,229
+389% +$71M
SAM icon
38
Boston Beer
SAM
$1.88B
$88.2M 0.4%
73,144
-23,779
-25% -$24.9M
ROKU icon
39
Roku
ROKU
$21.1B
$87.7M 0.4%
269,258
+229,709
+581% +$90M
EPAM icon
40
EPAM Systems
EPAM
$4.69B
$87.3M 0.4%
220,192
+42,284
+24% +$15.5M
RCL icon
41
Royal Caribbean
RCL
$78.7B
$87M 0.4%
1,016,418
-70,743
-7% -$5.61M
EXPE icon
42
Expedia Group
EXPE
$31.2B
$86.9M 0.4%
504,689
+415,523
+466% +$63.9M
TMUS icon
43
T-Mobile US
TMUS
$193B
$86.2M 0.4%
688,133
+97,170
+16% +$12.2M
ALC icon
44
Alcon
ALC
$33.1B
$86.1M 0.39%
1,224,574
+995,182
+434% +$70.5M
LQD icon
45
PUT
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$34.7B
$85M 0.39%
+653,400
New +$86.9M
GLD icon
46
CALL
SPDR Gold Trust
GLD
$131B
$83.1M 0.38%
+519,300
New +$87.3M
SABR icon
47
Sabre
SABR
$656M
$82.6M 0.38%
5,578,937
+1,452,917
+35% +$19.7M
WBD icon
48
Warner Bros
WBD
$64.6B
$80.5M 0.37%
1,852,604
+1,612,143
+670% +$80.5M
AON icon
49
Aon
AON
$77.3B
$79.4M 0.36%
+344,899
New +$75.9M
QQQ icon
50
CALL
Invesco QQQ Trust
QQQ
$455B
$78.9M 0.36%
247,200
-18,900
-7% -$6.04M

Similar funds

Marshall Wace's Q1 2021 Portfolio in Review

As of Q1 2021, Marshall Wace held 3,109 positions worth $21.8B, up 18% from $18.5B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Marshall Wace deployed $2.78B of net new capital in Q1 2021, opening 1,280 new positions and adding to 559 existing holdings. Its largest new stake was Paramount Global Class B: 5,936,494 shares worth $268M.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 28% a quarter earlier, followed by Consumer Discretionary and Technology.

On the sell side, the largest reduction was Thermo Fisher Scientific, an estimated $204M trimmed.

  • Marshall Wace's largest Q1 2021 buy was Paramount Global Class B: 5,936,494 shares worth $268M.
  • Marshall Wace added most to Farfetch Limited Class A Ordinary Shares in Q1 2021, an estimated $182M increase.
  • Marshall Wace's biggest Q1 2021 reduction was Thermo Fisher Scientific, cutting an estimated $204M.
  • Marshall Wace fully exited Vanguard Intermediate-Term Corporate Bond ETF in Q1 2021, selling an estimated $76.2M.
  • Marshall Wace's ten largest holdings make up 12% of its $21.8B portfolio in Q1 2021.
  • Marshall Wace opened 1,280 new positions and closed 699 in Q1 2021.
  • Marshall Wace's portfolio value rose 18% quarter-over-quarter to $21.8B.

Based on Marshall Wace's 13F filing for Q1 2021, filed 17 May 2021.